At least 50 million preschool-aged children globally are at risk of getting schistosomiasis. In the future, the new drug will ...

The Pediatric Praziquantel Consortium says it has achieved a milestone by administering arpraziquantel to the first preschool-aged child for the treatment of schistosomiasis, otherwise known as snail ...